Ponatinib vs Imatinib for Ph+ ALL, Cholesterol from Childhood to Adulthood and CVD Risk, Causal Inference, and more
- Author
- American Medical Association
- Published
- Tue 04 Jun 2024
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2024.1790
Editor’s Summary by Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for the June 4, 2024, issue.
